Preventing HIV among young people: Research priorities for the future

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue SUPPL. 2, 2013, Pages

  Pettifor, Audrey ^a,b,c   Bekker, Linda Gail ^d   Hosek, Sybil ^e   DiClemente, Ralph ^f   Rosenberg, Molly ^a   Bull, Sheana S ^g   Allison, Susannah ^h   Delany Moretlwe, Sinead ^b   Kapogiannis, Bill G ⁱ   Cowan, Frances ^j,k  

^a IL   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e Jr Hospital of Cook County   (United States)

^f EMORY UNIVERSITY   (United States)

^g Global Health and Health Disparities   (United States)

^h NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

ⁱ EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k CENTRE FOR SEXUAL HEALTH AND HIV AIDS RESEARCH   (Zimbabwe)

more..

Author keywords

Adolescence; HIV; Prevention

Indexed keywords

MICROBICIDE; TENOFOVIR;

ADOLESCENT HEALTH; ARTICLE; CIRCUMCISION; COMMUNITY CARE; CONDOM USE; DRUG EFFICACY; HEALTH EDUCATION; HETEROSEXUALITY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MEDICATION COMPLIANCE; MEN WHO HAVE SEX WITH MEN; PATIENT COUNSELING; PHASE 2 CLINICAL TRIAL (TOPIC); POVERTY; PREEXPOSURE PROPHYLAXIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SEX DIFFERENCE; SEXUAL TRANSMISSION; SOCIAL DISCRIMINATION; SOCIAL ENVIRONMENT; SOCIAL STIGMA; SOUTH AFRICA; UNPLANNED PREGNANCY; VIOLENCE;

ADOLESCENT; ADOLESCENT BEHAVIOR; BEHAVIORAL RESEARCH; BIOMEDICAL RESEARCH; FEMALE; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; PRIMARY PREVENTION; YOUNG ADULT;

EID: 84880191682     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31829871fb     Document Type: Article

References (85)

1. Nugent R. Youth in a Global World. Washington, DC: Population Reference Bureau; 2006.
2. UNAIDS. UNAIDS Report on the Global AIDS Epidemic. UN Joint Programme on HIV/AIDS: Geneva, Switzerland. 2010.
3. Gouws E, Stanecki KA, Lyerla R, et al. The epidemiology of HIV infection among young people aged 15-24 years in southern Africa. AIDS. 2008;22(suppl 4):S5-S16.
4. Pettifor AE, Rees HV, Kleinschmidt I, et al. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS. 2005;19:1525-1534.
5. The Panel on Transitions to Adulthood. Growing up Global: The Changing Transitions to Adulthood in Developing Countries: a Review of Published Data. National Academies Press: Washington, DC. 2005.
6. Schmithorst VJ, Yuan W. White matter development during adolescence as shown by diffusion MRI. Brain Cogn. 2010;72:16-25.
7. Casey BJ, Jones RM, Hare TA. The adolescent brain. Ann N Y Acad Sci. 2008;1124:111-126.
8. Erikson EH. Childhood and Society. New York, NY: W. W. Norton & Company; 1950.
9. Erikson EH. Identity: Youth and Crisis. New York, NY: W. W. Norton & Company; 1968.
10. Brooks-Gunn J, Graber J. What's sex got to do with it? The development of sexual identities during adolescence. In: Contrada RJ, Ashmore RD, eds. Self, Social Identity and Physical Health. 1st ed. Oxford, United Kingdom: Oxford University Press; 1999; 155-184.
11. Flisher AJ, Chalton DO. Adolescent contraceptive non-use and covariation among risk behaviors. J Adolesc Health. 2001;28:235-241.
12. Swartz L, Kagee A, Kafaar Z, et al. Social and behavioral aspects of child and adolescent participation in HIV vaccine trials. J Int Assoc Physicians AIDS Care (Chic). 2005;4:89-92.
13. Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008;372:669-684.
14. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
15. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367: 399-410.
16. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643-656.
17. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007; 369:657-666.
18. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363:2587-2599.
19. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168-1174.
20. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preex-posure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423-434.
21. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. New Engl J Med. 2012;367:411-422.
22. Marrazzo J, Ramjee G, Nair G, et al. Pre-Exposure Prophylaxis for HIV in Women: Daily Oral Tenofovir, Oral Tenofovir/Emtricitabine, or Vaginal Tenofovir Gel in the VOICE Study (MTN 003). Conference on Ret-roviruses and Opportunistic Infections. Atlanta, GA: 2013.
23. Amico KR, Mansoor LE, Corneli A, et al. Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials. AIDS Behav. 2013 Feb 23 [Epub ahead of print].
24. Murnane PM, Celum C, Kahle EM, et al. Daily Oral Pre-Exposure Prophylaxis in Highly Effective Among Subsets of Highest-risk Participants: Partners PrEP Study. Conference of Retroviruses and Opportunistic Infections (CROI). Atlanta, GA: 2013.
25. Belzer ME, Fuchs DN, Luftman GS, et al. Antiretroviral adherence issues among HIV-positive adolescents and young adults. J Adolesc Health Official Publ Soc Adolesc Med. 1999;25:316-319.
26. Fetzer BC, Mupenda B, Lusiama J, et al. Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: insights from a qualitative study. AIDS Patient Care STDS. 2011;25: 611-621.
27. Murphy DA, Wilson CM, Durako SJ, et al. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001;13:27-40.
28. Barclay TR, Hinkin CH, Castellon SA, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26:40-49.
29. Rudy BJ, Murphy DA, Harris DR, et al. Patient-related risks for non-adherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions. AIDS Patient Care STDS. 2009;23:185-194.
30. Bain-Brickley D, Butler LM, Kennedy GE, et al. Interventions to improve adherence to antiretroviral therapy in children with HIV infection. Cochrane Database Syst Rev. 2011;12:CD009513.
31. Fernandez MI, Hosek S, Warren JC, et al. Development of an easy to use tool to assess HIV treatment readiness in adolescent clinical care settings. AIDS care. 2011;23:1492-1499.
32. Garvie PA, Flynn PM, Belzer M, et al. Psychological factors, beliefs about medication, and adherence of youth with human immunodeficiency virus in a multisite directly observed therapy pilot study. J Ado-lesc Health. 2011;48:637-640.
33. Gray WN, Janicke DM, Fennell EB, et al. Piloting behavioral family systems therapy to improve adherence among adolescents with HIV: a case series intervention study. J Health Psychol. 2011;16:828-842.
34. Wohl AR, Garland WH, Wu J, et al. A youth-focused case management intervention to engage and retain young gay men of color in HIV care. AIDS care. 2011;23:988-997.
35. Pugatch D, Bennett L, Patterson D. HIV medication adherence in adolescents. J HIV/AIDS Prevention & Education for Adolescents & Children. 2002;5:9-29.
36. Facts. Follow-on African Consortium for tenofavir studies (FACTS). Available at: http://www.iprexnews.com/pdfswhatisnew/FACTS-Overview- June2011.pdf. Accessed February 1, 2013.
37. Microbicide Trials Network 017: a phase 2 randomized sequence open label expanded safety and acceptability study of oral emtricitabine/tenofovir disoproxil fumarate tablet and rectally-applied tenofovir reduced-glycerin 1% gel. Available at: http://www.mtnstopshiv.org/news/studies/mtn017. Accessed March 7, 2013.
38. Thurman A, Clark M, Doncel G. Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies. Infect Dis Obstet Gynecol. 2011;2011:1-10.
39. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298.
40. Jaspan H, Tucker T, Wright P, et al. Inclusion of adolescents in pre-ventative HIV vaccine trials: public health policy and research design at a crossroads. J Acquir Immune Defic Syndr. 2008;47:86-92.
41. DiClemente RJ, Ruiz MS, Sales JM. Barriers to adolescents' participation in HIV biomedical prevention research. J Acquir Immune Defic Syndr. 2010;54(suppl 1):S12-S7.
42. Nelson RM, Lewis LL, Struble K, et al. Ethical and regulatory considerations for the inclusion of adolescents in HIV biomedical prevention research. J Acquir Immune Defic Syndr. 2010;54(suppl 1):S18-S24.
43. Jaspan HB, Soka NF, Strode AE, et al. Community perspectives on the ethical issues surrounding adolescent HIV vaccine trials in South Africa. Vaccine. 2008;26:5679-5683.
44. Pettifor A, Bekker LG. Adolescent enrolment in HIV prevention trials. Lancet. 2012;380:646.
45. Kamali A, Quigley M, Nakiyingi J, et al. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet. 2003;361:645-652.
46. Koblin B, Chesney M, Coates T. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet. 2004;364: 41-50.
47. Padian NS, McCoy SI, Karim SS, et al. HIV prevention transformed: the new prevention research agenda. Lancet. 2011;378:269-278.
48. Centers for Disease Control and Prevention. Compendium of evidence-based HIV behavioral interventions. Available at: http://www.cdc.gov/hiv/topics/ research/prs/compendium-evidence-based-interventions.htm. Accessed October 22, 2012.
49. Cowan FM, Pascoe SJ, Langhaug LF, et al. The Regai Dzive Shiri project: results of a randomized trial of an HIV prevention intervention for youth. AIDS. 2010;24:2541-2552.
50. Ross DA, Changalucha J, Obasi AI, et al. Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a community-randomized trial. AIDS. 2007;21:1943-1955.
51. Doyle AM, Ross DA, Maganja K, et al. Long-term biological and behavioural impact of an adolescent sexual health intervention in Tanzania: follow-up survey of the community-based MEMA kwa Vijana Trial. PLoS Med. 2010;7:e1000287.
52. Ross D. Preventing HIV/AIDS in Young People: A Systematic Review of the Evidence From Developing Countries: UNAIDS Interagency Task Team on HIV and Young People. Geneva, Switzerland: WHO Press; 2006.
53. Napierala-Mavedzenge S, Doyle A, Ross D. HIV prevention among young people in subSaharan Africa: a systematic review. In: Ross D, ed. London, United Kingdom: Department of Epidemiology and Population Health, LSHTM; 2010;49:568-586.
54. Mathews C, Aarø LE, Grimsrud A, et al. Effects of the SATZ teacher-led school HIV prevention programmes on adolescent sexual behaviour: cluster randomised controlled trials in three sub-Saharan African sites. Int Health. 2012;4:111-122.
55. Michielsen K, Chersich MF, Luchters S, et al. Effectiveness of HIV prevention for youth in sub-Saharan Africa: systematic review and meta-analysis of randomized and nonrandomized trials. AIDS. 2010;24:1193-1202.
56. Sharer MF, Fullem A. Transitioning of Care and Other Services for Adolescents Living with HIV in Sub-Saharan Africa. Arlington, VA: AIDSTAR-One; 2012.
57. McCoy SI, Watts CH, Padian NS. Preventing HIV infection: turning the tide for young women. Lancet. 2010;376:1281-1282.
58. Dartnall E, Jewkes R. Sexual violence against women: the scope of the problem. Best Pract Res Clin Obstet Gynaecol. 2013;27:3-13.
59. Jewkes R, Sikweyiya Y, Morrell R, et al. The relationship between intimate partner violence, rape and HIV amongst South African men: a cross-sectional study. PLoS One. 2011;6:e24256.
60. Ross D, Dick B, Ferguson J. Preventing HIV/AIDS in Young People: A Systematic Review of the Evidence From Developing Countries: UNAIDS Interagency Task Team on HIV and Young People. Geneva, Switzerland: World Health Organization; 2006.
61. MietAfrica. Literature Review: Youth-Friendly Health Services. Miet Africa: Durban: South Africa. 2011.
62. WHO, FCH, CAH. Adolescent Friendly Health Services-An Agenda for Change. Geneva, Switzerland: World Health Organization; 2002.
63. Centers for Disease Control and Prevention. HIV testing among adolescents: what schools and education agencies can do. Available at: www.cdc.gov/healthyyouth/sexualbehaviors/pdf/hivtesting-adolescents.pdf. Accessed February 2013.
64. Barnighausen T, Hosegood V, Timaeus IM, et al. The socioeconomic determinants of HIV incidence: evidence from a longitudinal, population-based study in rural South Africa. AIDS. 2007;21(suppl 7):S29-S38.
65. Hargreaves JR, Bonell CP, Morison LA, et al. Explaining continued high HIV prevalence in South Africa: socioeconomic factors, HIV incidence and sexual behaviour change among a rural cohort, 2001-2004. AIDS. 2007;21(suppl 7):S39-S48.
66. Madise N, Zulu E, Ciera J. Is poverty a driver for risky sexual behaviour? Evidence from national surveys of adolescents in four African countries. Afr J Reprod Health. 2007;11:83-98.
67. Msisha WM, Kapiga SH, Earls F, et al. Socioeconomic status and HIV seroprevalence in Tanzania: a counterintuitive relationship. Int J Epidemiol. 2008;37:1297-1303.
68. Baird SJ, Garfein RS, McIntosh CT, et al. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012;379: 1320-1329.
69. HIV Prevention Trials Network. HPTN 068: effects of cash transfer for the prevention of HIV in young South African women. Available at: http://www.hptn.org/research-studies/hptn068.asp. Accessed November 1, 2012.
70. National Institute of Health. Reducing HIV in adolescents (RHIVA). Available at: http://clinicaltrials.gov/ct2/show/NCT01187979. Accessed November 1, 2012.
71. Bharath-Kumar U, Becker-Benton A, Lettenmaier C, et al. Communication and the antiretroviral treatment rollout: beyond the medical model. AIDS Educ Prev. 2009;21:447-459.
72. Horrigan J. Mobile access to data and information. 2008. Available at: http://www.pewinternet.org/Reports/2008/Mobile-Access-to-Data-and-Information. aspx. Accessed January 24, 2012.
73. Rainie L. The rise of cell phone text messaging. 2005. Available from: http://www.pewinternet.org/Commentary/2005/March/The-Rise-of-Cell-Phone-Text- Messaging.aspx. Accessed January 24, 2012.
74. NielsenWire. Cellphones and global youth: mobile internet and messaging trends. 2011. Available at: http://blog.nielsen.com/nielsenwire/online-mobile/ cellphones-and-global-youth-mobile-internet-and-messagingtrends/. Accessed January 22, 2012.
75. Kreutzer T. Assessing cell phone usage in a South African township school. Int J Educ Devel. 2009;5:43-57.
76. Bull SS. Technology Based Health Promotion. 1st ed. Thousand Oaks, CA: Sage; 2010.
77. Albarracin D, Gillette JC, Earl AN, et al. A test of major assumptions about behavior change: a comprehensive look at the effects of passive and active HIV-prevention interventions since the beginning of the epidemic. Psychol Bull. 2005;131:856-897.
78. Albarracin D, Kumkale GT, Johnson BT. Influences of social power and normative support on condom use decisions: a research synthesis. AIDS Care. 2004;16:700-723.
79. Jemmott JB III, Jemmott LS. HIV risk reduction behavioral interventions with heterosexual adolescents. AIDS. 2000;14(suppl 2):S40-S52.
80. Moreno MA, Vanderstoep A, Parks MR, et al. Reducing at-risk adolescents' display of risk behavior on a social networking web site: a randomized controlled pilot intervention trial. Arch Pediatr Adolesc Med. 2009;163:35-41.
81. Bull SS, Breslin LT, Wright EE, et al. Case study: an ethics case study of HIV prevention research on Facebook: the Just/Us study. J Pediatr Psy-chol. 2011;36:1082-1092.
82. Levine D, Madsen A, Wright E, et al. Formative research on MySpace: online methods to engage hard-to-reach populations. J Health Commun. 2011;16:448-454.
83. Juzang I, Fortune T, Black S, et al. A pilot programme using mobile phones for HIV prevention. J Telemed Telecare. 2011;17:150-153.
84. Levine D, McCright J, Dobkin L, et al. SEXINFO: a sexual health text messaging service for San Francisco youth. Am J Public Health. 2008; 98:393-395.
85. Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376:1838-1845.